SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-06
👔
Monte Rosa Therapeutics, Inc.
@GLUE_InsiderForm 4 Filing: Behbahani Ali Acquires shares of $GLUE
INSIDER TRANSACTION
⚡ MATERIALITY: 1/10
corporate issuer
Monte Rosa Therapeutics, Inc.
Ticker: $GLUE
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-01
Shares: 1,030,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Behbahani Ali, holds the title of Director at Monte Rosa Therapeutics, Inc..
On 2026-07-01, the insider transacted 1,030,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Behbahani Ali (Director) transacted $0 of $GLUE
Post-Transaction Position: 6,692,298 shares
SEC Accession No: 0001193125-26-296490 (CIK: 1613867)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.